ResMed (RMD) Misses Q2 EPS by 5c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.47, $0.05 worse than the analyst estimate of $1.52. Revenue for the quarter came in at $894.9 million versus the consensus estimate of $935.3 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- CalPrivate Bank names Andra Frazier as chief credit officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
